Koers TruTrace Technologies Inc Canadian Securities Exchange
Aandelen
CA8984471075
Geavanceerde medische apparatuur & technologie
Omzet 2021 | 0,16 0,22 0,15 | Omzet 2022 | 0,12 0,16 0,11 | Marktkapitalisatie | 3,82 mln. 5,22 mln. 3,52 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -1,37 mln. -922K | Nettowinst (verlies) 2022 | -2 mln. -2,73 mln. -1,84 mln. | EV/omzet 2021 | 83.773.009 x |
Nettoliquiditeiten 2021 | 893K 1,22 mln. 823K | Nettoschuld 2022 | 681K 931K 628K | EV/omzet 2022 | 37.973.468 x |
K/w-verhouding 2021 |
-6,71
x | K/w-verhouding 2022 |
-1,64
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 87,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 11-10-11 | |
Robert Lelovic
DFI | Director of Finance/CFO | - | 16-06-21 |
James LaValle
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cesare Fazari
BRD | Director/Board Member | - | 09-03-20 |
Robert Galarza
BRD | Director/Board Member | 45 | 17-05-18 |
Allan O'Dette
CHM | Chairman | - | 06-11-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,49% | 32,82 mld. | |
+20,93% | 7,95 mld. | |
+30,81% | 4,39 mld. | |
-30,09% | 2,65 mld. | |
-13,90% | 1,49 mld. | |
-16,59% | 1,48 mld. | |
-35,41% | 1,12 mld. | |
+11,17% | 994 mln. | |
-39,85% | 840 mln. |